Inhibikase Therapeutics
(NASDAQ) IKT
Inhibikase Therapeutics Financials at a Glance
Market Cap
$218.28M
Revenue (TTM)
$0.00
Net Income (TTM)
$47.66M
EPS (TTM)
$-0.57
P/E Ratio
-3.16
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$1.75
Volume
18,508
Open
$1.80
Price
$1.75
Volume
18,508
Open
$1.80
Previous Close
$1.75
Daily Range
$1.71 - $1.83
52-Week Range
$1.33 - $2.46
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$1.75
Volume
18,508
Open
$1.80
Previous Close
$1.75
Daily Range
$1.71 - $1.83
52-Week Range
$1.33 - $2.46
IKT News
IKT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Inhibikase Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
16
CEO
Mark T. Iwicki, MBA
Website
www.inhibikase.comHeadquarters
Atlanta, GA 30339, US
IKT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-132%
Return on Capital
-71%
Return on Assets
-60%
Earnings Yield
-31.65%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$218.28M
Shares Outstanding
121.27M
Volume
18.51K
Short Interest
0.00%
Avg. Volume
1.76M
Financials (TTM)
Gross Profit
$26.27K
Operating Income
$28.59M
EBITDA
$27.49M
Operating Cash Flow
$19.15M
Capital Expenditure
$0.00
Free Cash Flow
$19.15M
Cash & ST Invst.
$97.54M
Total Debt
$110.52K
Inhibikase Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$23.69K
-260.7%
Gross Margin
0.00%
N/A
Market Cap
$218.28M
N/A
Market Cap/Employee
$14.55M
N/A
Employees
15
N/A
Net Income
$11.93M
-106.5%
EBITDA
$11.91M
-104.5%
Quarterly Fundamentals
Net Cash
$77.32M
+2454.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-59.87%
N/A
Return on Invested Capital
-70.81%
N/A
Free Cash Flow
$10.59M
-117.0%
Operating Cash Flow
$10.59M
-117.0%